900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent and dependent manner

Míreanna comhchosúla

• 234 Distinct efficacy and immunological responses to αPD-1, αPD-L1 and αPD-L2 immunotherapy in aged versus young hosts
  de réir: Tyler Curiel, et al.
  Foilsithe / Cruthaithe: (2021-11-01)
• 4579 Distinct clinical and immunological responses to αPD-1, kαPD-L1 and αPD-L2 immunotherapy in B16 melanoma in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences
  de réir: Myrna G Garcia, et al.
  Foilsithe / Cruthaithe: (2020-06-01)
• 755 Pharmacologic tumor PD-L1 depletion reduces Chk2 content and sensitizes tumors to small molecule Chk1 DNA damage repair inhibitors
  de réir: Tyler Curiel, et al.
  Foilsithe / Cruthaithe: (2021-11-01)
• 421 Specific cephalosporin antibiotics deplete tumor PD-L1 to inhibit DNA damage sensing and sensitize to Chk1 inhibitors in vivo
  de réir: Clare Murray, et al.
  Foilsithe / Cruthaithe: (2022-04-01)
• PD-1 and PD-L1 expression in rare lung tumors
  de réir: Marton Gyulai, et al.
  Foilsithe / Cruthaithe: (2023-05-01)